| 0 |
UNADJUSTED DOSE ADMINISTERED |
6 |
0.0882 |
| 1 |
HEREDITARY ANGIOEDEMA |
218 |
0.0203 |
| 2 |
PHLEBOSCLEROSIS |
1 |
0.0128 |
| 3 |
PARAINFLUENZA VIRUS INFECTION |
1 |
0.0097 |
| 4 |
BREATH SOUNDS ABSENT |
1 |
0.0091 |
| 5 |
PARATRACHEAL LYMPHADENOPATHY |
1 |
0.0082 |
| 6 |
INFECTIVE GLOSSITIS |
1 |
0.0064 |
| 7 |
FEMALE REPRODUCTIVE TRACT DISORDER |
1 |
0.0046 |
| 8 |
TETHERED CORD SYNDROME |
1 |
0.0045 |
| 9 |
PILONIDAL DISEASE |
1 |
0.0042 |
| 10 |
VAGUS NERVE DISORDER |
1 |
0.0040 |
| 11 |
VASCULAR ACCESS SITE COMPLICATION |
1 |
0.0040 |
| 12 |
MALABSORPTION FROM INJECTION SITE |
1 |
0.0032 |
| 13 |
LUNG PERFORATION |
1 |
0.0030 |
| 14 |
OESOPHAGEAL MOTILITY DISORDER |
1 |
0.0028 |
| 15 |
VAGINAL PROLAPSE |
1 |
0.0023 |
| 16 |
LACK OF SPONTANEOUS SPEECH |
1 |
0.0023 |
| 17 |
CRANIAL NERVE PARALYSIS |
1 |
0.0021 |
| 18 |
BRAIN NEOPLASM BENIGN |
1 |
0.0020 |
| 19 |
AUTOSCOPY |
1 |
0.0019 |
| 20 |
EJACULATION DELAYED |
1 |
0.0018 |
| 21 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
8 |
0.0018 |
| 22 |
BLOOD OESTROGEN INCREASED |
1 |
0.0017 |
| 23 |
UNINTENTIONAL USE FOR UNAPPROVED INDICATION |
1 |
0.0017 |
| 24 |
PRECANCEROUS CONDITION |
1 |
0.0015 |
| 25 |
HEAT EXHAUSTION |
1 |
0.0012 |
| 26 |
INCORRECT DOSAGE ADMINISTERED |
6 |
0.0012 |
| 27 |
MYCOTIC ALLERGY |
1 |
0.0012 |
| 28 |
SPINAL CORD NEOPLASM |
1 |
0.0011 |
| 29 |
SELECTIVE EATING DISORDER |
1 |
0.0011 |
| 30 |
ANIMAL SCRATCH |
1 |
0.0010 |
| 31 |
SLEEP DEFICIT |
2 |
0.0009 |
| 32 |
FACIAL SPASM |
1 |
0.0009 |
| 33 |
DENTAL OPERATION |
2 |
0.0008 |
| 34 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 35 |
INSURANCE ISSUE |
12 |
0.0008 |
| 36 |
ENDOCRINE DISORDER |
1 |
0.0008 |
| 37 |
DRUG EFFECT LESS THAN EXPECTED |
11 |
0.0007 |
| 38 |
MIGRAINE WITH AURA |
2 |
0.0007 |
| 39 |
INJECTION SITE SCAR |
2 |
0.0007 |
| 40 |
FAT TISSUE INCREASED |
1 |
0.0007 |
| 41 |
SKIN STRIAE |
1 |
0.0007 |
| 42 |
TONGUE COATED |
1 |
0.0006 |
| 43 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 44 |
GASTRIC INFECTION |
2 |
0.0005 |
| 45 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 46 |
EJACULATION FAILURE |
1 |
0.0005 |
| 47 |
CHANGE OF BOWEL HABIT |
1 |
0.0005 |
| 48 |
HORDEOLUM |
2 |
0.0005 |
| 49 |
MIDDLE EAR EFFUSION |
1 |
0.0005 |
| 50 |
SPINAL COLUMN INJURY |
1 |
0.0004 |
| 51 |
TONGUE BLISTERING |
1 |
0.0004 |
| 52 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 53 |
PRODUCT DISTRIBUTION ISSUE |
4 |
0.0004 |
| 54 |
BREATH ODOUR |
1 |
0.0004 |
| 55 |
BRONCHITIS CHRONIC |
1 |
0.0004 |
| 56 |
DERMAL CYST |
1 |
0.0004 |
| 57 |
VASODILATATION |
1 |
0.0004 |
| 58 |
MENOPAUSE |
1 |
0.0004 |
| 59 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
1 |
0.0004 |
| 60 |
LARYNGOSPASM |
1 |
0.0004 |
| 61 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 62 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 63 |
STREPTOCOCCAL INFECTION |
2 |
0.0004 |
| 64 |
THERAPEUTIC RESPONSE DELAYED |
1 |
0.0004 |
| 65 |
NEUROLOGICAL SYMPTOM |
2 |
0.0003 |
| 66 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 67 |
HYPERCAPNIA |
1 |
0.0003 |
| 68 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 69 |
EMERGENCY CARE |
1 |
0.0003 |
| 70 |
BREAST CANCER RECURRENT |
1 |
0.0003 |
| 71 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 72 |
LYME DISEASE |
1 |
0.0003 |
| 73 |
POTENTIATING DRUG INTERACTION |
1 |
0.0003 |
| 74 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV |
1 |
0.0003 |
| 75 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 76 |
FOOT FRACTURE |
5 |
0.0003 |
| 77 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 78 |
ORAL INFECTION |
1 |
0.0003 |
| 79 |
PRODUCT DOSE OMISSION IN ERROR |
7 |
0.0002 |
| 80 |
SPINAL FUSION SURGERY |
1 |
0.0002 |
| 81 |
SHOULDER OPERATION |
1 |
0.0002 |
| 82 |
ANURIA |
2 |
0.0002 |
| 83 |
URINE OUTPUT DECREASED |
2 |
0.0002 |
| 84 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 85 |
ROSACEA |
1 |
0.0002 |
| 86 |
FLANK PAIN |
2 |
0.0002 |
| 87 |
SKIN ABRASION |
1 |
0.0002 |
| 88 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 89 |
HERNIA |
4 |
0.0002 |
| 90 |
INCORRECT DOSE ADMINISTERED |
47 |
0.0002 |
| 91 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 92 |
PANCREATIC DISORDER |
1 |
0.0002 |
| 93 |
LIGAMENT SPRAIN |
2 |
0.0002 |
| 94 |
ANEURYSM |
1 |
0.0002 |
| 95 |
VEIN DISORDER |
1 |
0.0002 |
| 96 |
TOOTH ABSCESS |
2 |
0.0002 |
| 97 |
PHLEBITIS |
1 |
0.0002 |
| 98 |
TONSILLITIS |
1 |
0.0002 |
| 99 |
BRAIN FOG |
3 |
0.0002 |
| 100 |
FOOD POISONING |
1 |
0.0002 |
| 101 |
CHEILITIS |
1 |
0.0002 |
| 102 |
PHARYNGITIS STREPTOCOCCAL |
2 |
0.0002 |
| 103 |
HIP SURGERY |
1 |
0.0002 |
| 104 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 105 |
VIRAL INFECTION |
6 |
0.0002 |
| 106 |
ODYNOPHAGIA |
1 |
0.0002 |
| 107 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 108 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 109 |
ADVERSE REACTION |
2 |
0.0002 |
| 110 |
EAR INFECTION |
4 |
0.0002 |
| 111 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 112 |
LIMB INJURY |
4 |
0.0001 |
| 113 |
ECCHYMOSIS |
1 |
0.0001 |
| 114 |
HAND FRACTURE |
1 |
0.0001 |
| 115 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 116 |
THERAPY INTERRUPTED |
10 |
0.0001 |
| 117 |
PARALYSIS |
2 |
0.0001 |
| 118 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 119 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 120 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 121 |
PULMONARY MASS |
2 |
0.0001 |
| 122 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 123 |
APHTHOUS ULCER |
1 |
0.0001 |
| 124 |
SWELLING |
12 |
0.0001 |
| 125 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 126 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 127 |
FURUNCLE |
1 |
0.0001 |
| 128 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 129 |
CARDIAC OPERATION |
1 |
0.0001 |
| 130 |
MYOPATHY |
1 |
0.0001 |
| 131 |
CARDIAC MURMUR |
1 |
0.0001 |
| 132 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 133 |
THROAT TIGHTNESS |
3 |
0.0001 |
| 134 |
LIP DRY |
1 |
0.0001 |
| 135 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 136 |
APPENDICITIS |
1 |
0.0001 |
| 137 |
LEUKAEMIA |
1 |
0.0001 |
| 138 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 139 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 140 |
KIDNEY INFECTION |
2 |
0.0001 |
| 141 |
THERAPY CHANGE |
1 |
0.0001 |
| 142 |
PRESCRIBED UNDERDOSE |
2 |
0.0001 |
| 143 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 144 |
SPINAL FRACTURE |
2 |
0.0001 |
| 145 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 146 |
INFLUENZA |
11 |
0.0001 |
| 147 |
WEIGHT INCREASED |
22 |
0.0001 |
| 148 |
RIB FRACTURE |
2 |
0.0001 |
| 149 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 150 |
DENTAL CARIES |
1 |
0.0001 |
| 151 |
LIP SWELLING |
3 |
0.0001 |
| 152 |
TOOTH DISORDER |
2 |
0.0001 |
| 153 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 154 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 155 |
CHROMATURIA |
2 |
0.0001 |
| 156 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 157 |
NEPHROLITHIASIS |
4 |
0.0001 |
| 158 |
METASTASES TO LUNG |
1 |
0.0001 |
| 159 |
DYSPHAGIA |
8 |
0.0001 |
| 160 |
LOCALISED INFECTION |
2 |
0.0001 |
| 161 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 162 |
PHARYNGITIS |
1 |
0.0001 |
| 163 |
TOOTH EXTRACTION |
1 |
0.0001 |
| 164 |
ILLNESS |
8 |
0.0001 |
| 165 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 166 |
DRUG INEFFECTIVE |
102 |
0.0001 |
| 167 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 168 |
TOOTH INFECTION |
1 |
0.0001 |
| 169 |
DYSMENORRHOEA |
1 |
0.0001 |
| 170 |
PRODUCT DOSE OMISSION ISSUE |
22 |
0.0001 |
| 171 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 172 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 173 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 174 |
HUNGER |
1 |
0.0001 |
| 175 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 176 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
5 |
0.0001 |
| 177 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 178 |
HYPERSOMNIA |
2 |
0.0001 |
| 179 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 180 |
DYSPHONIA |
4 |
0.0001 |
| 181 |
SINUSITIS |
7 |
0.0001 |
| 182 |
WEIGHT DECREASED |
19 |
0.0001 |
| 183 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 184 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
12 |
0.0001 |
| 185 |
FEELING HOT |
4 |
0.0001 |
| 186 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 187 |
RENAL DISORDER |
3 |
0.0001 |
| 188 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 189 |
ABSCESS |
1 |
0.0001 |
| 190 |
GAIT INABILITY |
2 |
0.0001 |
| 191 |
PRODUCT USE ISSUE |
11 |
0.0001 |
| 192 |
ABDOMINAL DISTENSION |
6 |
0.0001 |
| 193 |
HEADACHE |
36 |
0.0001 |
| 194 |
NERVOUSNESS |
3 |
0.0001 |
| 195 |
COLD SWEAT |
1 |
0.0001 |
| 196 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 197 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 198 |
GASTROINTESTINAL DISORDER |
5 |
0.0001 |
| 199 |
ADVERSE DRUG REACTION |
5 |
0.0001 |
| 200 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 201 |
PELVIC PAIN |
1 |
0.0001 |
| 202 |
NASOPHARYNGITIS |
10 |
0.0001 |
| 203 |
HYPERSENSITIVITY |
10 |
0.0001 |
| 204 |
URTICARIA |
9 |
0.0001 |
| 205 |
FRACTURE |
1 |
0.0001 |
| 206 |
COLITIS |
2 |
0.0001 |
| 207 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 208 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 209 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 210 |
ERUCTATION |
1 |
0.0001 |
| 211 |
EAR PAIN |
1 |
0.0001 |
| 212 |
CHOKING |
1 |
0.0001 |
| 213 |
PREGNANCY |
1 |
0.0000 |
| 214 |
FEEDING DISORDER |
1 |
0.0000 |
| 215 |
MOUTH ULCERATION |
1 |
0.0000 |
| 216 |
RETCHING |
1 |
0.0000 |
| 217 |
JOINT INJURY |
1 |
0.0000 |
| 218 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 219 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 220 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 221 |
SWELLING FACE |
3 |
0.0000 |
| 222 |
MENTAL DISORDER |
2 |
0.0000 |
| 223 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 224 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 225 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 226 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 227 |
MIGRAINE |
4 |
0.0000 |
| 228 |
PRESYNCOPE |
1 |
0.0000 |
| 229 |
NEURALGIA |
1 |
0.0000 |
| 230 |
EPISTAXIS |
3 |
0.0000 |
| 231 |
HYPOPHAGIA |
1 |
0.0000 |
| 232 |
FALL |
13 |
0.0000 |
| 233 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 234 |
VOMITING |
18 |
0.0000 |
| 235 |
DEAFNESS |
1 |
0.0000 |
| 236 |
SPEECH DISORDER |
2 |
0.0000 |
| 237 |
GASTRITIS |
1 |
0.0000 |
| 238 |
DEPRESSED MOOD |
2 |
0.0000 |
| 239 |
DRUG INTERACTION |
6 |
0.0000 |
| 240 |
DEHYDRATION |
5 |
0.0000 |
| 241 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 242 |
DRY MOUTH |
3 |
0.0000 |
| 243 |
RASH PRURITIC |
2 |
0.0000 |
| 244 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 245 |
DIVERTICULITIS |
1 |
0.0000 |
| 246 |
FEELING COLD |
1 |
0.0000 |
| 247 |
PAIN IN JAW |
1 |
0.0000 |
| 248 |
INFECTION |
5 |
0.0000 |
| 249 |
ABDOMINAL PAIN |
8 |
0.0000 |
| 250 |
NEEDLE ISSUE |
1 |
0.0000 |
| 251 |
PRURITUS |
13 |
0.0000 |
| 252 |
ADVERSE EVENT |
3 |
0.0000 |
| 253 |
HOSPITALISATION |
5 |
0.0000 |
| 254 |
PERIPHERAL SWELLING |
5 |
0.0000 |
| 255 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 256 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 257 |
CYSTITIS |
1 |
0.0000 |
| 258 |
CONTUSION |
3 |
0.0000 |
| 259 |
HYPERHIDROSIS |
4 |
0.0000 |
| 260 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 261 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 262 |
SYNCOPE |
3 |
0.0000 |
| 263 |
URINARY RETENTION |
1 |
0.0000 |
| 264 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 265 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 266 |
MALAISE |
13 |
0.0000 |
| 267 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 268 |
FEELING ABNORMAL |
7 |
0.0000 |
| 269 |
BURNING SENSATION |
2 |
0.0000 |
| 270 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 271 |
DYSURIA |
1 |
0.0000 |
| 272 |
EYE SWELLING |
1 |
0.0000 |
| 273 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 274 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 275 |
DIZZINESS |
13 |
0.0000 |
| 276 |
PALPITATIONS |
3 |
0.0000 |
| 277 |
ARTHRITIS |
2 |
0.0000 |
| 278 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 279 |
HYPOTENSION |
5 |
0.0000 |
| 280 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 281 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 282 |
OSTEOPOROSIS |
1 |
0.0000 |
| 283 |
TREMOR |
4 |
0.0000 |
| 284 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 285 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 286 |
OVERDOSE |
5 |
0.0000 |
| 287 |
SEPTIC SHOCK |
1 |
0.0000 |
| 288 |
RASH |
10 |
0.0000 |
| 289 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 290 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 291 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 292 |
ANGIOEDEMA |
1 |
0.0000 |
| 293 |
LIVER DISORDER |
1 |
0.0000 |
| 294 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 295 |
PNEUMONIA |
7 |
0.0000 |
| 296 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 297 |
RENAL CANCER |
1 |
0.0000 |
| 298 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 299 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 300 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 301 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 302 |
DRY EYE |
1 |
0.0000 |
| 303 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 304 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 305 |
PARAESTHESIA |
3 |
0.0000 |
| 306 |
NAUSEA |
15 |
0.0000 |
| 307 |
PANCREATITIS |
1 |
0.0000 |
| 308 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 309 |
OEDEMA |
1 |
0.0000 |
| 310 |
SEPSIS |
2 |
0.0000 |
| 311 |
PAIN |
11 |
0.0000 |
| 312 |
BLISTER |
1 |
0.0000 |
| 313 |
HERPES ZOSTER |
1 |
0.0000 |
| 314 |
SEIZURE |
2 |
0.0000 |
| 315 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 316 |
BACK PAIN |
4 |
0.0000 |
| 317 |
COVID-19 |
3 |
0.0000 |
| 318 |
BONE PAIN |
1 |
0.0000 |
| 319 |
CHILLS |
2 |
0.0000 |
| 320 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 321 |
STOMATITIS |
1 |
0.0000 |
| 322 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 323 |
INJECTION SITE PAIN |
5 |
0.0000 |
| 324 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 325 |
CHEST PAIN |
3 |
0.0000 |
| 326 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 327 |
OFF LABEL USE |
14 |
0.0000 |
| 328 |
RHINORRHOEA |
1 |
0.0000 |
| 329 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 330 |
INSOMNIA |
4 |
0.0000 |
| 331 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 332 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 333 |
VISION BLURRED |
2 |
0.0000 |
| 334 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 335 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 336 |
COUGH |
4 |
0.0000 |
| 337 |
SLEEP DISORDER |
1 |
0.0000 |
| 338 |
FATIGUE |
11 |
0.0000 |
| 339 |
MOBILITY DECREASED |
1 |
0.0000 |
| 340 |
BRONCHITIS |
1 |
0.0000 |
| 341 |
HYPOAESTHESIA |
2 |
0.0000 |
| 342 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 343 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 344 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 345 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 346 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 347 |
DIARRHOEA |
8 |
0.0000 |
| 348 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 349 |
MYALGIA |
2 |
0.0000 |
| 350 |
PYREXIA |
4 |
0.0000 |
| 351 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 352 |
TACHYCARDIA |
1 |
0.0000 |
| 353 |
DEVICE ISSUE |
1 |
0.0000 |
| 354 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 355 |
BREAST CANCER |
1 |
0.0000 |
| 356 |
CARDIAC DISORDER |
1 |
0.0000 |
| 357 |
DYSPNOEA |
6 |
0.0000 |
| 358 |
ANXIETY |
3 |
0.0000 |
| 359 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 360 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 361 |
DYSPEPSIA |
1 |
0.0000 |
| 362 |
HEART RATE INCREASED |
1 |
0.0000 |
| 363 |
SOMNOLENCE |
2 |
0.0000 |
| 364 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 365 |
ERYTHEMA |
2 |
0.0000 |
| 366 |
CONSTIPATION |
2 |
0.0000 |
| 367 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 368 |
JOINT SWELLING |
1 |
0.0000 |
| 369 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 370 |
ASTHENIA |
3 |
0.0000 |
| 371 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 372 |
ARTHRALGIA |
3 |
0.0000 |
| 373 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 374 |
MUSCLE SPASMS |
1 |
0.0000 |
| 375 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 376 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 377 |
ALOPECIA |
1 |
0.0000 |
| 378 |
HYPERTENSION |
1 |
0.0000 |
| 379 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 380 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 381 |
DEATH |
2 |
0.0000 |